Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HEC110114 in HCV-infected Subjects
NCT04202952Phase 2Completed
- Sponsor
- Sunshine Lake Pharma
- Start
- Jul 2020
- Primary completion
- Aug 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of encofosbuvir in hepatitis C (HCV), sponsored by Sunshine Lake Pharma. Started Jul 2020; status: completed.
02
Drugs
encofosbuvir
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT04202952.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04202952.